The effect of Cinnarizine on Autism

Phase 3

• Conditions: autism spectrum disorder.; Autistic disorder; F84.0

• Registration Number: IRCT20110628006907N16
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 January 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

Age between 2-7 years old
Diagnosed with Autism based on DSM5 criteria which is approved by a psychiatrist

Exclusion Criteria

Conditions other than Autism justifying the symptoms of patient

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient's score from the Behavioral problems questionnaire for people with intellectual disabilities. Timepoint: at the beginning of trial and 3 months later. Method of measurement: Behavioral problems questionnaire for people with intellectual disabilities.